Mahmood S - Search Results

1

Effect of TT virus co-infection on interferon response in chronic hepatitis C patients.

Kawanaka M, Niiyama G, Mahmood S, Ifukube S, Yoshida N, Onishi H, Hanano S, Ito T, Yamada G. Kawanaka M, et al. Among authors: mahmood s. Liver. 2002 Aug;22(4):351-5. doi: 10.1034/j.1600-0676.2002.01560.x. Liver. 2002. PMID: 12296969

2

Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C.

Mahmood S, Yamada G, Niiyama G, Kawanaka M, Togawa K, Sho M, Ito T, Sasagawa T, Okita M, Nakamura H, Yodoi J. Mahmood S, et al. Free Radic Res. 2003 Jul;37(7):781-5. doi: 10.1080/1071576031000102141. Free Radic Res. 2003. PMID: 12911275

3

Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C.

Mahmood S, Kawanaka M, Kamei A, Izumi A, Nakata K, Niiyama G, Ikeda H, Hanano S, Suehiro M, Togawa K, Yamada G. Mahmood S, et al. Antioxid Redox Signal. 2004 Feb;6(1):19-24. doi: 10.1089/152308604771978318. Antioxid Redox Signal. 2004. PMID: 14713333

4

Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.

Mahmood S, Niiyama G, Kamei A, Izumi A, Nakata K, Ikeda H, Suehiro M, Kawanaka M, Togawa K, Yamada G. Mahmood S, et al. Liver Int. 2005 Apr;25(2):220-5. doi: 10.1111/j.1478-3231.2005.01077.x. Liver Int. 2005. PMID: 15780042

5

Long term follow-up of a group of chronic hepatitis C patients treated with anti-inflammatory drugs following initial interferon therapy.

Mahmood S, Niiyama G, Kawanaka M, Nakata K, Sho M, Yasuhara Y, Ito T, Yamada G. Mahmood S, et al. Hepatol Res. 2002 Nov;24(3):213. doi: 10.1016/s1386-6346(02)00085-2. Hepatol Res. 2002. PMID: 12393022

6

Clinical significance of intrahepatic interleukin-8 in chronic hepatitis C patients.

Mahmood S, Sho M, Yasuhara Y, Kawanaka M, Niiyama G, Togawa K, Ito T, Takahashi N, Kinoshita M, Yamada G. Mahmood S, et al. Hepatol Res. 2002 Dec;24(4):413-419. doi: 10.1016/s1386-6346(02)00136-5. Hepatol Res. 2002. PMID: 12479940

7

An analysis of risk factors for developing Hepatocellular carcinoma in a group of Hepatitis C patients with stage 3 fibrosis following interferon therapy.

Mahmood S, Togawa K, Kawanaka M, Niiyama G, Yamada G. Mahmood S, et al. Cancer Inform. 2008;6:381-7. doi: 10.4137/cin.s644. Epub 2008 Apr 23. Cancer Inform. 2008. PMID: 19259418 Free PMC article.

8

Clinical usefulness of the branched DNA assay version 2 in predicting the efficacy of Interferon treatment in a group of chronic HCV patients based on serotype.

Mahmood S, Nakata K, Sho M, Kimura T, Manabe Y, Kinoyama S, Ito T, Yamada G. Mahmood S, et al. Hepatol Res. 2001 May 1;20(1):9-17. doi: 10.1016/s1386-6346(00)00118-2. Hepatol Res. 2001. PMID: 11282482

9

Control of oxidative stress and reduction in biochemical markers by Vitamin E treatment in patients with nonalcoholic steatohepatitis: a pilot study.

Kawanaka M, Mahmood S, Niiyama G, Izumi A, Kamei A, Ikeda H, Suehiro M, Togawa K, Sasagawa T, Okita M, Nakamura H, Yodoi J, Yamada G. Kawanaka M, et al. Among authors: mahmood s. Hepatol Res. 2004 May;29(1):39-41. doi: 10.1016/j.hepres.2004.02.002. Hepatol Res. 2004. PMID: 15135345 No abstract available.

10

Wilson's disease masquerading as nonalcoholic steatohepatitis.

Mahmood S, Inada N, Izumi A, Kawanaka M, Kobashi H, Yamada G. Mahmood S, et al. N Am J Med Sci. 2009 Jul;1(2):74-6. N Am J Med Sci. 2009. PMID: 22666674 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,770 results

Search Page

Filters